After acute myocardial infarction (AMI) cardiac enzymes and proteins are released into plasma and are used as biochemical markers of cardiac muscle injury. We studied the completeness of the release of troponin T, a cardiac protein that is largely bound to myofibrillar structures and compared it with the release of cytoplasmic cardiac enzymes in 22 patients with AMI, who were treated with thrombolytic therapy.
myocardial infarction (AMI).I-6 These studies demonstrated that the favourable effects of such therapy, namely preservation of myocardial function and reduced mortality, can be explained by limitation of infarct size and this has stimulated interest in the quantitative interpretation of enzymatic data and in the methodological aspects of such analysis.r" In order to allow comparison of the cumulative release of different cardiac enzymes and proteins, total enzyme or protein release per litre~f plasma is divided by the enzyme or prot~m content per gram wet weight of healthy cardiac tissue, so that myocardial injury can be expressed in gram-equivalents (g-eq) of healthy heart muscle per litre plasma (infarct size). 8.9 In this way it has been demonstrated that different cardiac enzymes such as creatine kinase (CK) and IX-hydroxybutyrate dehydrogenase (HBDH) produce approximately similar estima~es of infarct size in g-eq of heart muscle per litre of plasma. to Until now, no studies have been published on the quantification of troponin T release after AMI. In studies on the kinetics of troponin-T release after AMI, a characteristic biphasic change in plasma concentration is observed, especially in patients receiving thrombolytic therapy.U':" It has been suggested that intracellular compartmentation of troponin 1', i.e. the presence of both free cytosolic and structurall.y bound troponin 1', is the primary cause of this biphasic troponin-T release into plasma.I'v-Structurally bound troponin T has to be dissociated from the contractile myofibrillar structures before it can be released into the circulation. Therefore, earlier release of the free cytosolic fraction is to be expected. Katus!' found a free cytosolic fraction of 6%. These data were based on measurement of troponin-T content in only three different cardiac tissue samples, obtained from healthy donor organs. Further knowledge of cardiac troponin-T content is lacking, but is of special importance in studies on quantification of myocardial infarction from serum troponin-T concentrations.
Therefore we examined the enzyme [lactate dehydrogenase (LDH) and HBDH] and total troponin-T content of cardiac tissue obtained at autopsy. To allow comparison with the literature both LDH and HBDH were determined.
Moreover, cumulative release of troponin T was estimated from time-concentration plasma curves measured in patients with AMI, receiving thrombolytic therapy and whose blood was sampled for at least 168 h after the onset of symptoms. The cumulative release into plasma is expressed in g-eq tissue per litre plasma a.nd compared with cumulative release of the cardiac enzymes CK, HBDH (or LDH) in the same patients.
Cardiac troponin T release 31S PATIENTS AND MEmODS
Patients Patients (16 men and 6 women) presented at the Department of Cardiology of the. Hospital~e Wever en Gregorius in Heerlen, WIth chest pam and ST segment elevation typical of AMI within 6 h after the onset of symptoms, were treated with thrombolytic therapy. First 160 mg of aspirin was given (unless already given by general practitioner or ambulance nurses), followed by thrombolytic therapy which consisted of 1·S million units of streptokinase, given by infusion in 40 min. Four hours after starting thrombolytic therapy heparin was given, 12 500 units subcutaneous, every 12 h, for 5 days. All procedures followed were approved by the Medical Ethical Committee of the Hospital. All patients included in the study had given informed consent, and their mean age was 60 ± 8·S years [mean (SD), median 60 and range 39-78 years]. The mean treatment delay was 2·3±1·3 h [mean (SD), median 1·8 and range 0,7-5,3 h]. Patients with increased risk of bleeding, previous coronary by-pass surgery or Q-wave infarction in the same location, severe hepatic or renal disease, or inability to give informed consent were excluded from the study.
Venous blood samples of 10 mL were obtained just before starting thrombolytic therapy and 1, 2, 3, 4, 5, 6, 8, 10, 14, 18, 22, 28, 34, 46, 58, 70, 82, 94, 118, 142 , 166 h later. Exact sampling times were recorded and expressed as time after the onset of symptoms. Most samples were taken from indwelling catheters and care was taken to prevent haemolysis. Contamination with infused solutions was prevented by using a second catheter for infusion purposes. Blood was collected in pre-distributed and labelled tubes containing dry heparin to prevent clotting and was taken to the laboratory immediately. Plasma samples, obtained after routine centrifugation, were stored at -70°C until analysis. Table I . About 4 em from the apex a transmural tissue sample of about 2 g was cut from the anterior wall of the left ventricle, bordering the septum.
Enzyme content per gram wet weight of myocardium Epicardial fat was removed from the tissue and, after gentle blotting to remove adhering moisture, an approximately 0·5 g transmural sample of the left ventricle was taken and weighed. Each sample was homogenized separately (Ultraturrax, Janke and Kunkel, type 18-10) and sonicated (Sonorex Baudelin, type RK 102 H, 120-240 W, 35 kHz). Homogenization, in 10 bursts and sonification in five60 s bursts, were performed in tubes kept on ice and containing 9·5 mL of a 4% pasteurized plasma protein solution (The Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands). The suspension was centrifuged at 2000 x g for 15 min and the supernatant was immediately stored at -70°C until enzyme analysis.'! In healthy dog hearts this procedure resulted in IG-12% overall variation in enzyme content, including 4---6% intra-assay scatter for cardiac enzymes."
Troponin-T content per gram wet weight of myocardium ' For the determination of total troponin-T content the method described by Katus was used.'! A transmural sample was weighed and O· 5 g was homogenized in 10 vol of prechilled low-ionic strength buffer (0'05 M tris hydrochloride, pH 7,0, 7·0 mM ethylene dinitrilotetraacetic acid, 0'5 mM dithiotreitol), using five bursts of 15 s duration with an Ultra Turrax homogenizer. The homogenate was then stirred for I h at 4°C. Thereafter, insoluble molecules were sedimented by ultracentrifugation (100000 x g) for I h. This extraction step for soluble cytosolic molecules was repeated twice. The resulting supernatants were saved for measurement of cytosolic troponin-T concentrations. Troponin T was extracted from the insoluble precipitated myofibrils by homogenization of the precipitate in pH 7·0 buffer containing 0·4 M potassium chloride, 0·1 M potassium dihydrogen phosphate, 0·05 M potassium monohydrogen phosphate, O'O~M sodium pyrophosphate, 0·01 M magnesium chloride, and stirring for I h at 4°C. The solubilized troponin-T complex was separated from insoluble actomyosin and cellular debris by centrifugation at 20 000 g for I h. Fractions for troponin-T analysis were frozen at -70°C until analysis of the total troponin-T content which was expressed as 20 J.lg/g wet weight of tissue.
Calculation of cumulative release of enzymes and troponin T into plasma Q(t), the cumulative release of enzyme activity and troponin-T concentration per litre of plasma from the onset of AMI (t = 0) up to time t, was calculated with the following expression for a two-compartment model:
The three terms are the enzyme activity in plasma, the extravasated activity and the activity eliminated from plasma, all three expressed per Cardiac troponin T release 317 litre of plasma. The parameters TER, ERR and FCR represent the fractional rate constants for transcapillary escape, extravascular return and catabolism of activity, respectively. This twocompartment model has been validated in the dog 16 • 18 and parameter values estimated in man are.l?
FCRHBDHor LOH = 0·015 h-I , FCRcK = 0·20 h-1 , TER = 0·014 h-1 and ERR = 0.018 h~l For troponin T, a value of FCR = 0·11 ± 0·05 h-1 [mean(SD)] was obtained from a fitting procedure on troponin T and HBDH plasma curves, as described by Willems. 19 The procedure is based on simultaneous release of the two proteins from the same (cytoplasmic) compartment, that is, the released troponin T should be the free cytosolic fraction. Therefore, fitting was limited to the first 24 h after first symptoms and it was verified that fitting over 18 or 30 h gave similar results, which indicates that the release of fibrillar troponin T remains negligible during this period. The mean obtained value of FCR ' T = 0·11 h -I was used in the calculatroporun tions. Plasma enzyme activities measured at time t, CCt), were corrected by subtraction of the normal steady-state activities Cs' If the first plasma sample was obtained within 4 h after the onset of symptoms, the corresponding enzyme activities were used for C s' In the remaining three cases, fixed mean values of 100 U/L, 112 U/L, 260 U/L and 0 J.lg/L were used for CK, HBDH, LDH and troponin T, respectively. Expression of infarct size in g-eq of tissue per litre of plasma In order to express myocardial injury in g-eq of healthy myocardium per litre of plasma, the cumulative release of enzymes per litre of plasma was divided by the respective enzyme content per gram of wet weight of cardiac tissue. For CK the enzyme content per gram wet weight of tissue was obtained from the literature. CK content has to be determined in fresh myocardium obtained at cardiosurgery, because CK is decreased in samples obtained at autopsy.'! Therefore, a CK-content of 865 U/g wet weight measured in fresh cardiac biopsies obtained after cardiosurgery was used. 20 The value was converted to an equivalent value at 37°C, by multiplication by 2,5, giving a CK content of 2163 U/g wet weight. LDH and HBDH are not susceptible to autolysis and the enzyme content in samples obtained at autopsy is comparable with the enzyme content in samples of fresh myocardial tissue.P LDH and HBDH content were determined in the same 17 hearts obtained at autopsy used for determination of troponin-T content.
Statistical analysis
The release curves for proteins into plasma are presented as means with standard error of the mean (SEM). Tissue enzyme and troponin-T contents Data on the LDH, HBDH and troponin-T content in 17 myocardial autopsies are presented in Table 1 and in Fig. 2 . For HBDH a mean tissue content of 156±25 Ujg and for LDH of 385 ± 59·4 U jg were found. For total troponin T a mean concentration of 234±65 J1.gjg wet weight was found.
RESULTS

Mean plasma CK and HBDH activity and troponin-T concentration
Cumulative release of enzymes into plasma As 'shown in Fig. 3 , CK and HBDH (or LDH) are released simultaneously and total release is completed within 72 h. Figure 3 also shows that the cumulatively released quantities of CK and HBDH (or LDH) amount to approximately similar estimates of the extent of injury, i.e. infarct size. Mean (SEM, n = 22) values for Q (72) in the first 72 h after AMI, were 12 827±3439 UjL, 925±248 UjL and 2337 ± 635, UL for CK, HBDH and LDH, respectively. When expressed in g-eq of tissue per litre of plasma these figures became 5·9 ± 1'5, 5·9 ± 1·6 and 6·1 ± 1·7 g-eqjL, respectively, and these differences are obviously not statistically significantly different.
Cumulative release of troponin T into plasma
The mean cumulative release of troponin T after 72 h was 69·4 ± 20·9 J-IgjL. When expressed in g-eq of tissue per litre plasma only O' 30 ± 0·09 g-eqjL was released into plasma. After 168 h the cumulative mean troponin-T release into plasma was 119± 36·8 J-IgjL and expressed in g-eq of indicate that troponin-T release still continues after 168 h ( Fig. 3) , while the release of CK and HBDH (or LDH) is already completed after 72 h. After 72 h the recovery of troponin T is only 5% and after 168 h only 8·5% of the recovery of the cytoplasmic enzymes CK and HBDH (or LDH) after 72 h (Fig. 3) .
Estimation of the free troponin-T fraction from plasma enzyme release In the first 24 h mainly free cytoplasmic enzymes and proteins are released into the circulation and the biphasic plasma release of troponin T in Fig. 1 
DISCUSSION
Correlation between infarct size calculated with different markers Correlations between infarct size calculated from plasma curves ( Table 2) , using HBDH as a reference versus cumulative CK or cumulative troponin-T release are shown in Fig. 4 . Although the mean total release of troponin T after 72 h amounts to only O'30 g-eq/L, which is only 5% of the mean total release observed for HBDH after 72 h (5'9 g-eq/L), a highly significant correlation was observed between cumulative HBDH release and cumulative troponin-T release after 72 h (r=0'82, Fig.4b ) and also with cumulative troponin-T release after 168 h (r = 0'84, Fig. 4c ). The highest correlation was observed between Q HBDH and Q CK after 72 h [r = 0·96 (Fig. 4a) ]. One outlying patient (No. 12) with an infarct size for CK, HBDH and troponin T (at 72 h) of, respectively, 29,1, 35·5 and 2·03 g-eq/L is not depicted in Fig. 4 (see Table 2 ). A highly significant correlation (P<O'OOOl) was also found between cumulative HBDH release after 72 h and the first (r = O' 86) or the second troponin-T peak value (r=0·86). The correlation coefficient for peak CK and peak HBDH values for these patients was even higher (r=0'95, P<O·OOOl). troponin T into plasma would also correspond to the cytosolic troponin-T release from 4 g-eq myocardium, which is to be expected, the value of 40 JJ.g/L for cumulative troponin-T release over 24 h would imply 10 JJ. free troponin T per gram wet weight of myocardium, that is 4·2% of total troponin-T content.
Disappearance rates from plasma cannot be used in the calculation of troponin-T release When plasma protein levels have passed their maximal value and are returning to normal, there is a tailing off of release of protein from the heart. Due to this continued release, the fractional rate constant k d for the apparent disappearance from plasma is much lower than the true clearance constant FCR. It has been shown in the dog, for instance, that the k d for the disappearance of CK from plasma after coronary ligation is about three times lower than FCR.17 The same is true for troponin T in the present study. The calculated value of FCR = 0·11 h -1 is about three to four times higher than the maximal disappearance rate of FIGURE amounting -1 % to -6% in the first 10 h for CK, HBDH and AST. Comparison of myocardial enzyme activities in biopsies with those obtained at autopsy the latter being corrected for autolysis-induced inactivation, revealed significant differences for CK and AST, but not for HBDH and LDH content. Van der Laarse observed an' HBDH content of 123±15 U/g determined at 25°C. Using a temperature correction factor of 1·3 (see Methods) this results in a content of 160±20 U/g wet weight, which is in accordance with the value of 156±25 Ulg wet weight observed in the present study, determined at 37°. For LDH 166±22 UI g was found by Van der Laarse/" and using a temperature correction factor of 2·1 (see Methods), this results in an LDH content of 349±46 U/g. This is slightly lower, but comparable with the LDH content of 385±59 U/g observed in the present study.
Correlation between (a) cumulative hydroxybutyrate dehydrogenase (HBDH) and CK (creatine kinase) and (b) between cumulative HBDH and troponin-T release at
Very few data are available on cardiac tissue troponin-T content. Katus!' determined the free troponin-T fraction in myocardium of three healthy donor organs and observed 24 ± 7 jJ.g/g wet weight, which represented 6 ± 1·1% of the total troponin-T content, being 400 Jlg/g wet weight. We found a total troponin-T content of 234 ± 65 jJ.g/g, and no effect of autolysis (Fig. 2) . Autolysis is the destruction of tissues or organs caused by endogenous enzyme activity after death. Figure 2 shows that there is no relation between autopsy delay (influence of autolysis) and troponin-T content. This might indicate that, as described for CK20 in post-mortem cardiac samples, although the time of autopsy has no effect, a higher concentration is still found in biopsies than in material obtained at autopsy. In the present study tissue was obtained at autopsy and this might clarify the differences, although further investigation is necessary. For actomyosin preparations prepared from human myocardium, also obtained post mortem, proteolysis of troponin T has been described, especially for preparations isolated from elderly subjects. However, the decrease of troponin T in these preparations was not quantified." Moreover, the autopsy samples were obtained from elderly or probably cachectic subjects, and this might also cause the larger variations found for troponin T, although for the data presented there was no relation between patient age and troponin-T content. We used exactly the same procedure and the same assay conditions as described by Katus. II Troponin T was measured in all supernatants and precipitates, so recovery Cardiac troponin T release 321 was complete. Further comparison of troponin-T content in fresh biopsies compared with autopsy material is required. The coefficient of variation of 27% for total troponin-T content in Table 1 is larger than the values found for HBDH or LDH, but comparable with those found for HBDH and aspartate aminotransferase (AST) in the hearts of patients who died from non-cardiac causes by van Veen et aUI Differentiation of cytoplasmic from bound troponin T resulted in an overestimation of the cytosolic fraction, probably caused by autolysis. Therefore we only presented the total troponin-T content.
Complete recovery in plasma of cytoplasmic proteins lost from the heart Quantitative recovery of cardiac proteins in plasma after ischaemic myocardial damage has been demonstrated in experimental studies. The total activities of CK and HBDH lost from dog heart after permanent coronary occlusion, 17 equalled the total amounts of these proteins released into plasma. These results cannot be directly extrapolated to man. It was shown in the dog that protein preparations infused into infarcted myocardium reach the circulation within a few hours.P Such a rapid washout of protein is effected by direct intravasation and flushing of the microvessels by the residual blood flow in the infarcted area. In man, conditions could be different and the washout period may be longer. However, the fact that similar estimates of infarct size are obtained for different enzymes suggest that, in man, these cytoplasmic proteins are recovered completely in plasma.v" CK is very susceptible to inactivation but in contrast, HBDH ('heat stable' LDH) is more stable. Since estimates of infarct size from CK and HBDH were similar, the effects of denaturation must be small.
Quantification of cumulative troponin-T release
Using a total cardiac troponin-T content of 234 jJ.g/g ( Table 1 ) the cumulative troponin-T release after 72 h is only 5% and after 168 h only 8·5% of the cumulative release of cytoplasmic enzymes after 72 h, when expressed in g-eq of normal cardiac tissue (Fig. 3) . Using the troponin-T cardiac tissue content found by Katus of 400 jJ.g/g,lI a mean cumulative release of troponin T is obtained of only 0·26 g-eq/L at 72 h, which is 4% of the cumulative enzyme release at that time. Although lower than the value obtained in the present study, this difference is insufficient to detract from the conclusion that troponin-T release amounts to only a small fraction (4%-5%) of total tissue content.
Estimation of free cytosolic troponin-T release from the plasma time activity curve The free cytoplasmic troponin-T concentration extrapolated from the plasma enzyme release in the first 24 h suggests an in vivo free cytosolic troponin-T fraction of 10 J.lg/g wet weight of tissue, which is 4·2% of the total troponin-T content found in cardiac tissue obtained at autopsy (234 J.lg/g) and only 2·5% of the total troponin-T content of 400 J.lg/g found by Katus" in fresh human donor hearts.
Limitations of troponin T for estimation of infarct size
Estimation of the extent of ischaemic myocardial injury from the release of cardiac enzymes into plasma has become normal clinical practice. Several clinical studies have produced convincing correlations between enzymatic and histologic estimates of infarct size. n - 27 In our study, the correlation between the cumulative cytoplasmic HBDH and cumulative CK release is higher (r=0'96, n=21, P<O·OOOI) compared to the correlation between the cumulative HBDH and cumulative troponin-T release (r=0'84, n=21, P<O·OOOI). Recently, Omura 28 showed a good correlation between the late troponin-T peak and left ventricular ejection fraction (r=0'68), injury extent score (r=0'71) and severity score (r = 0'66). In the study, a good correlation was also obtained between cumulative HBDH release (infarct size) and both the first troponin-T peak (r=0'86, n=21, P<O'OOOI) and the second troponin-T peak (r=0'86, n=21, P<O·OOOI). These good correlations are due in part to the very frequent sampling scheme employed.
The present study shows that although cumulative troponin-T release is only a fraction of the cumulative enzyme release, there is a good correlation between cumulative cytoplasmic enzyme release (infarct size) and cumulative troponin-T release, and also between cumulative cytoplasmic enzyme release and peak troponin-T values.
